Physicians' Academy for Cardiovascular Education

Lipid management in Qatar in High CV-risk Patients: Why do we need novel therapeutics?

Dec. 17, 2016 - Qatar - Dr. Hani Sabbour, Abu Dhabi, UAE - Master Class - PCSK9 Inhibiion in Clinical Lipid Management

Educational information

This session is recorded at Master Class - PCSK9 Inhibition in Clinical Lipid Management

Disclosures

Dr Hani Sabbour is Consultant Cardiologist and Electrophysiologist -Clinical Professor of Cardiology, Cardiology Department Sheikh Khalifa Medical Center, Abu Dhabi , UAE

Funding

The meeting was sponsored by Sanofi Gulf